liarozole has been researched along with isotretinoin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biesalski, H; Grundl, W; Kornhuber, HH; Westarp, ME; Westarp, MP | 1 |
Fudge, K; Stearns, ME; Wang, M | 1 |
2 other study(ies) available for liarozole and isotretinoin
Article | Year |
---|---|
Improving medical approaches to primary CNS malignancies--retinoid therapy and more.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Cell Differentiation; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Humans; Imidazoles; Isotretinoin; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Retinoids; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Vitamin A | 1993 |
Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Adhesion; Cell Division; Cell Survival; Chemotactic Factors; Collagenases; Disease Models, Animal; Humans; Imidazoles; Isotretinoin; Male; Matrix Metalloproteinase 9; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Transplantation; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |